Medical News

RSS

KGI scientists identify new gene regulator that keeps hearts healthy even under intense exercise

Providing a medical explanation for why exercise is good for the heart, a team of scientists from Brazil pursuing a study that started in Dr. Ian Phillips' lab at Keck Graduate Institute (KGI) has discovered a new gene regulator called MicroRNA 29 that keeps hearts healthy even under intense exercise.

3 Jun 2011

IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease

IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.

3 Jun 2011

Syndax receives U.S. patent for entinostat to treat metastatic cancers

Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the United States Patent and Trademark Office of Patent Application Serial No. 12/549458 entitled: " N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL)- METHOXYCARBONYL—AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."

3 Jun 2011

PQA honors Kaiser Permanente for outstanding performance in medication safety

Kaiser Permanente Colorado is one of only three health plans in the nation to receive a top honor for excellence in medication safety. The award, issued by the Pharmacy Quality Alliance, recognizes Kaiser Permanente's outstanding performance on medication safety measures included in the Centers for Medicare and Medicaid Services (CMS) new 5-star rating program.

3 Jun 2011

Opinion: Integrate NTD, HIV, TB and malaria programs

In a New England Journal of Medicine opinion piece, Peter Hotez of the Sabin Vaccine Institute and colleagues, including Jeffrey Sachs of the Earth Institute of Columbia University, outline how integrating treatment of neglected tropical diseases (NTD) into HIV/AIDS, tuberculosis and malaria control efforts could speed up progress toward attaining the sixth Millennium Development Goal.

3 Jun 2011

Scientists identify protein sorting mechanism used by salivary gland

University of Louisville researchers are one step closer to helping millions of people whose salivary glands no longer work because of disease or damage from treatment of diseases.

3 Jun 2011

U-M study shows decline in surgery mortality for eight different high-risk operations

Surgery death rates have dropped nationwide over the past decade, according to a University of Michigan Health System study that reveals cancer surgeries have seen the most dramatic improvement in safety.

3 Jun 2011

Scientists uncover new therapeutic target that could prevent stress-related cell death

Scientists from the Florida campus of The Scripps Research Institute have uncovered a potentially important new therapeutic target that could prevent stress-related cell death, a characteristic of neurodegenerative diseases such as Parkinson's, as well as heart attack and stroke.

3 Jun 2011

Rheonix to receive U.S. patent for powerful microfluidic platform

Rheonix, Inc., developer of the Rheonix CARD system that provides a powerful microfluidic platform for the evolving molecular diagnostics industry, announced that on June 14, 2011 the U.S. Patent and Trademark Office will issue Patent Number 7,959,875, "Microfluidic Chips and Assay Systems," and on April 13, 2011 it allowed Patent Application Number 11/594,444, "Microfluidic Systems," to the Company.

3 Jun 2011

Editorial: Food security should be a priority

"Any system that produces enough food for the entire world and yet fails to feed one in seven people, which is subject to rampant speculation and land-grabbing, and where crops and land that could be used to feed people are instead turned into fuel for Hummers, is patently not working," a Guardian editorial says.

3 Jun 2011

Green tea consumption increases number of 'regulatory T cells', prevents autoimmune disease

One of the beneficial compounds found in green tea has a powerful ability to increase the number of "regulatory T cells" that play a key role in immune function and suppression of autoimmune disease, according to new research in the Linus Pauling Institute at Oregon State University.

3 Jun 2011

Scientists discover new compound that inhibits bitterness

Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.

3 Jun 2011

'Provision of choice' strategy helps improve vegetable consumption in children

A gesture as simple as allowing children to freely choose the vegetables they want to eat helps to increase the consumption of these foods in children, as University of Granada has found.

3 Jun 2011

VCU Massey completes Bortezomib-Alvocidib Phase I clinical trial against blood cancers

Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.

3 Jun 2011

Geophagy protects stomach against toxins, parasites and pathogens

Most of us never considered eating the mud pies we made as kids, but for many people all over the world, dining on dirt is nothing out of the ordinary. Now an extensive meta-analysis forthcoming in the June issue of The Quarterly Review of Biology helps explain why.

3 Jun 2011

LabCorp extends cash tender offer for all shares of Orchid common stock

Laboratory Corporation of America Holdings today announced that LabCorp is extending until 6:00 p.m., New York City time, on June 15, 2011, LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc.

3 Jun 2011

Elevated CRP levels predict poor prognosis of breast cancer

Levels of C-reactive protein (CRP) are increased in response to acute inflammation, infection and tissue damage. There are also reports that CRP levels are elevated because of cancer.

3 Jun 2011

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.

3 Jun 2011

Editorial: U.S. must provide ample funding for GAVI

"Considering its wealth, the U.S. spends relatively little on humanitarian aid that can make an enormous difference in the lives of millions of people - and in the perception of the U.S. around the world. Nothing this nation could do with $450 million would surpass the good accomplished with a vaccination pledge to GAVI,".

3 Jun 2011

VisiInc and MMRGlobal announce agreement to launch MyMedicalRecords in Australia

MMRGlobal, Inc. and VisiInc PLC (VZJ) have entered into an agreement to launch MMRGlobal’s patented consumer and professional health IT products and services, including MMRPro for healthcare professionals (www.mmrprovideos.com) and the MyMedicalRecords Personal Health Record (PHR) (www.mmrvideos.com), on the Visi™ platform utilizing the Vistime product. Initially, the two companies will collaborate on offering products and services jointly to the health technology market in Australia, which is currently projected to be as much as $2.4 billion this year.

2 Jun 2011

Medical News

KGI scientists identify new gene regulator that keeps hearts healthy even under intense exercise

IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease

Syndax receives U.S. patent for entinostat to treat metastatic cancers

PQA honors Kaiser Permanente for outstanding performance in medication safety

Opinion: Integrate NTD, HIV, TB and malaria programs

Scientists identify protein sorting mechanism used by salivary gland

U-M study shows decline in surgery mortality for eight different high-risk operations

Scientists uncover new therapeutic target that could prevent stress-related cell death

Rheonix to receive U.S. patent for powerful microfluidic platform

Editorial: Food security should be a priority

Green tea consumption increases number of 'regulatory T cells', prevents autoimmune disease

Scientists discover new compound that inhibits bitterness

'Provision of choice' strategy helps improve vegetable consumption in children

VCU Massey completes Bortezomib-Alvocidib Phase I clinical trial against blood cancers

Geophagy protects stomach against toxins, parasites and pathogens

LabCorp extends cash tender offer for all shares of Orchid common stock

Elevated CRP levels predict poor prognosis of breast cancer

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

Editorial: U.S. must provide ample funding for GAVI

VisiInc and MMRGlobal announce agreement to launch MyMedicalRecords in Australia

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News